<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>US provides Ebola treatment for outbreak in Congo, bringing trials closer — Live Feed</title><link>https://www.live-feeds.com/feed/us-provides-ebola-treatment-for-outbreak-in-congo-bringing-trials-closer</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/us-provides-ebola-treatment-for-outbreak-in-congo-bringing-trials-closer/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>Ebola Treatment Trials Begin in Democratic Republic of Congo</title><link>https://www.live-feeds.com/feed/us-provides-ebola-treatment-for-outbreak-in-congo-bringing-trials-closer</link><guid isPermaLink="false">https://www.live-feeds.com/feed/us-provides-ebola-treatment-for-outbreak-in-congo-bringing-trials-closer#u24988</guid><pubDate>Sat, 04 Jul 2026 21:55:53 +0000</pubDate><description>Researchers started a study on Thursday to test two potential Ebola treatments in eastern Congo. The effort aims to improve survival rates as the outbreak grows. The World Health Organization is overseeing the clinical testing of these antiviral therapies.What's confirmed:Researchers began a study of two possible Ebola treatments on Thursday in eastern Congo.The World Health Organization announced the start of clinical testing for two antiviral therapy approaches.There are 438 deaths linked to the outbreak.Still unconfirmed:The Bundibugyo virus caused over 1,400 infections.There are 1,406 conf</description></item>
<item><title>US Provides Experimental Ebola Treatment for Congo Outbreak Trials</title><link>https://www.live-feeds.com/feed/us-provides-ebola-treatment-for-outbreak-in-congo-bringing-trials-closer</link><guid isPermaLink="false">https://www.live-feeds.com/feed/us-provides-ebola-treatment-for-outbreak-in-congo-bringing-trials-closer#u16825</guid><pubDate>Mon, 29 Jun 2026 05:07:29 +0000</pubDate><description>The United States has supplied doses of an experimental antibody drug from Mapp Biopharmaceutical for clinical trials in the Democratic Republic of Congo. This move supports efforts to combat a widening Ebola outbreak. The WHO indicates that trials for two drugs are scheduled to begin next week.What's confirmed:The US provided doses of an experimental antibody drug from Mapp Biopharmaceutical for clinical trials in the Democratic Republic of Congo.The US previously stated the antibody drug would be available only to Americans deemed to be at high risk.HHS sent the drug for the Ebola clinical t</description></item>
</channel></rss>